Cannabis Investing Kalytera Announces Engagement of Echelon Wealth Partners to Assist with Review of Potential Out-License Opportunities for Commercial Rights to GVHD Products
Cannabis Investing Kalytera Reports Data for First Cohort in Phase 2 Clinical Study Evaluating CBD in Prevention of Acute GVHD
Cannabis Investing Kalytera Announces Share Issuance for January Invoices under Payments Agreements with Salzman Group
Cannabis Investing Kalytera Announces Change to Scope of Services under Payments Agreements with Salzman Group and Next Share Issuance
Cannabis Investing Kalytera Announces Closing of Private Placement of Common Shares and Common Share Purchase Warrants
Cannabis Investing Kalytera Announces Closing of Private Placement of Common Shares and Common Share Purchase Warrants
Cannabis Investing Kalytera Announces Share Issuance and Extension to March 1 under Payments Agreements with Salzman Group
Cannabis Investing Kalytera Announces Private Placement of Common Shares and Common Share Purchase Warrants
Big News Roundup: Kalytera Announces Issuance of Second Patent Covering the Use of CBD in Graft Versus Host Disease; Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis
RUA GOLD Expands High-Grade Intercepts at Depth at Auld Creek: 5.9g/t AuEq over 9m and 48.3g/t AuEq over 1.25m
Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis
